[go: up one dir, main page]

MX2022013593A - Composiciones, métodos, y sistemas para detectar staphylococcus aureus resistente a meticilina. - Google Patents

Composiciones, métodos, y sistemas para detectar staphylococcus aureus resistente a meticilina.

Info

Publication number
MX2022013593A
MX2022013593A MX2022013593A MX2022013593A MX2022013593A MX 2022013593 A MX2022013593 A MX 2022013593A MX 2022013593 A MX2022013593 A MX 2022013593A MX 2022013593 A MX2022013593 A MX 2022013593A MX 2022013593 A MX2022013593 A MX 2022013593A
Authority
MX
Mexico
Prior art keywords
methods
mrsa
compositions
systems
protein product
Prior art date
Application number
MX2022013593A
Other languages
English (en)
Inventor
Stephen Erickson
Minh Mindy Bao Nguyen
Matthew J Brown
Jose Gil
Original Assignee
Laboratory Corp America Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratory Corp America Holdings filed Critical Laboratory Corp America Holdings
Publication of MX2022013593A publication Critical patent/MX2022013593A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se divulgan composiciones, métodos y sistemas para detectar MRSA, por ejemplo, colonización nasal de MRSA. En ciertas modalidades, los métodos usan amplificación basada en bacteriófagos de la señal en la detección de bacterias y otros microorganismos para detectar MRSA. Los métodos para detectar MRSA pueden incluir preparar un ensayo que comprende un agente selectivo y un cóctel que comprende al menos dos tipos diferentes de bacteriófagos recombinantes, incubar la muestra en el ensayo, capturar un producto de proteína indicadora y detectar un producto de proteína indicadora producido por el bacteriófago recombinante, en donde la detección positiva del producto de proteína indicadora indica que MRSA está presente en la muestra.
MX2022013593A 2020-04-30 2021-04-30 Composiciones, métodos, y sistemas para detectar staphylococcus aureus resistente a meticilina. MX2022013593A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063018081P 2020-04-30 2020-04-30
PCT/US2021/030127 WO2021222723A1 (en) 2020-04-30 2021-04-30 Compositions, methods, and systems for detecting methicillin-resistant staphylococcus aureus

Publications (1)

Publication Number Publication Date
MX2022013593A true MX2022013593A (es) 2023-01-18

Family

ID=76059988

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013593A MX2022013593A (es) 2020-04-30 2021-04-30 Composiciones, métodos, y sistemas para detectar staphylococcus aureus resistente a meticilina.

Country Status (9)

Country Link
US (1) US20210341477A1 (es)
EP (1) EP4143570B1 (es)
JP (1) JP2023523627A (es)
CN (1) CN116018518A (es)
AU (1) AU2021265261A1 (es)
BR (1) BR112022022046A2 (es)
CA (1) CA3181416A1 (es)
MX (1) MX2022013593A (es)
WO (1) WO2021222723A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119688660B (zh) * 2024-12-23 2025-06-13 合肥工业大学 一种用于检测耐甲氧西林金黄色葡萄球菌的双探针检测试剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2485560A1 (en) * 2002-05-10 2004-06-03 Engeneos, Inc. Unique recognition sequences and methods of use thereof in protein analysis
CN102131915A (zh) * 2008-08-21 2011-07-20 3M创新有限公司 用于计数抗生素抗性微生物的方法和组合物
US10519483B2 (en) 2012-02-21 2019-12-31 Laboratory Corporation Of America Holdings Methods and systems for rapid detection of microorganisms using infectious agents
CN105531382A (zh) * 2013-06-19 2016-04-27 六品科技公司 基于噬菌体的细菌检测法
US11560584B2 (en) * 2016-12-30 2023-01-24 Quidel Corporation Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents
JP2020526188A (ja) * 2017-07-07 2020-08-31 ラボラトリー コーポレイション オブ アメリカ ホールディングス 抗生物質耐性の検出のための方法およびシステム
WO2019209982A1 (en) * 2018-04-24 2019-10-31 Laboratory Corporation Of America Holdings Indicator bacteriophage for selecting and monitoring for efficacy of therapeutics and methods for using same

Also Published As

Publication number Publication date
US20210341477A1 (en) 2021-11-04
EP4143570A1 (en) 2023-03-08
BR112022022046A2 (pt) 2022-12-13
CN116018518A (zh) 2023-04-25
WO2021222723A1 (en) 2021-11-04
JP2023523627A (ja) 2023-06-06
AU2021265261A1 (en) 2022-11-24
EP4143570B1 (en) 2025-12-03
CA3181416A1 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
Lunde et al. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II
Hong et al. Experimental induction of bacterial resistance to the antimicrobial peptide tachyplesin I and investigation of the resistance mechanisms
Dong et al. Construction of a chimeric lysin Ply187N‐V12C with extended lytic activity against staphylococci and streptococci
MX2025010971A (es) Bacteriofago indicador para seleccionar y monitorear la eficacia de agentes terapeuticos y metodos de uso del mismo
Zhang et al. Gingipains from the periodontal pathogen Porphyromonas gingivalis play a significant role in regulation of angiopoietin 1 and angiopoietin 2 in human aortic smooth muscle cells
Dhup et al. First report of identification of livestock-associated MRSA ST9 in retail meat in England
ECSP18081945A (es) Detección de infección microbiana en heridas
MX376189B (es) Metodos y sistemas para la deteccion rapida de microorganismos con el uso de bacteriofago recombinante.
WO2014205221A3 (en) Phage-based bacterial detection assay
Abdelkader et al. Engineering a lysin with intrinsic antibacterial activity (LysMK34) by cecropin a fusion enhances its antibacterial properties against Acinetobacter baumannii
Battin et al. A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samples
MX2014010069A (es) Metodos y sistemas para deteccion de microorganismos.
MX2018008778A (es) Metodos y sistemas de deteccion rapida de microorganismos utilizando agentes infecciosos.
Greco-Stewart et al. Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates
MX2022013593A (es) Composiciones, métodos, y sistemas para detectar staphylococcus aureus resistente a meticilina.
MX2021009094A (es) Metodos y sistemas para la deteccion rapida de listeria utilizando agentes infecciosos.
El Haddad et al. Characterization of a novel Panton-Valentine leukocidin (PVL)-encoding staphylococcal phage and its naturally PVL-lacking variant
EP3454888A1 (en) Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides
Aktas et al. Panton-Valentine leukocidin and biofilm production of Staphylococcus aureus isolated from respiratory tract
Weißelberg et al. Staphylococcus epidermidis alters macrophage polarization and phagocytic uptake by extracellular DNA release in vitro
Piechowicz et al. Staphylococcus aureus co-infection in COVID-19 patients: virulence genes and their influence on respiratory epithelial cells in light of risk of severe secondary infection
Yu et al. 2, 3-Dehydrokievitone combats methicillin-resistant Staphylococcus aureus infection by reducing alpha-hemolysin expression
BR112023022354A2 (pt) Composições e métodos para detecção multiplex de microrganismos usando agentes infecciosos recombinantes marcados com peptídeos
BR112022004479A2 (pt) Métodos e sistemas para a rápida detecção de microrganismos usando agentes infecciosas recombinantes para expressar uma subunidade indicadora
WO2021113457A3 (en) Differential detection of viral and bacterial infections